– Results presented from over a decade of treatment with velmanase alfa in alpha-mannosidosis – – Company also presents immunogenicity and tolerability data from pegunigalsidase alfa clinical trial program in Fabry disease – – Additional presentations provide new insights on prevalence,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.